Talphera (NASDAQ:TLPH) Stock Price Down 2.7% – Here’s Why

Talphera, Inc. (NASDAQ:TLPH)’s stock price fell 2.7% during trading on Monday . The company traded as low as $1.04 and last traded at $1.07. 189,221 shares were traded during trading, a decline of 55% from the average session volume of 416,292 shares. The stock had previously closed at $1.10.

Analysts Set New Price Targets

Several research analysts recently issued reports on TLPH shares. Weiss Ratings reissued a “sell (d-)” rating on shares of Talphera in a research note on Wednesday, October 8th. Wall Street Zen upgraded Talphera to a “hold” rating in a report on Saturday, November 1st. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat, Talphera has an average rating of “Moderate Buy” and a consensus price target of $5.00.

Talphera Price Performance

The company has a market cap of $49.87 million, a PE ratio of -2.82 and a beta of 0.25. The business has a fifty day simple moving average of $1.23 and a two-hundred day simple moving average of $0.85.

Talphera (NASDAQ:TLPH) last released its quarterly earnings results on Wednesday, November 12th. The company reported ($0.11) EPS for the quarter, topping the consensus estimate of ($0.12) by $0.01. On average, equities research analysts predict that Talphera, Inc. will post -0.64 EPS for the current year.

Institutional Investors Weigh In On Talphera

A number of hedge funds and other institutional investors have recently bought and sold shares of TLPH. AIGH Capital Management LLC acquired a new position in shares of Talphera during the third quarter worth $3,979,000. Rosalind Advisors Inc. boosted its position in shares of Talphera by 118.9% in the 3rd quarter. Rosalind Advisors Inc. now owns 4,385,757 shares of the company’s stock worth $3,917,000 after purchasing an additional 2,381,818 shares in the last quarter. Nantahala Capital Management LLC grew its stake in Talphera by 75.3% during the 3rd quarter. Nantahala Capital Management LLC now owns 3,492,519 shares of the company’s stock worth $3,120,000 after buying an additional 1,500,000 shares during the last quarter. Dauntless Investment Group LLC purchased a new position in Talphera during the 3rd quarter worth $89,000. Finally, Virtu Financial LLC acquired a new position in Talphera during the 3rd quarter valued at about $29,000. Hedge funds and other institutional investors own 37.67% of the company’s stock.

About Talphera

Talphera, Inc, a specialty pharmaceutical company, focuses on the development and commercialization of therapies for use in medically supervised settings. Its lead product candidate is Niyad, a lyophilized formulation of nafamostat, which is under an investigational device exemption as an anticoagulant for the extracorporeal circuit. It is also developing LTX-608, an anti-inflammatory and antiviral potential for the treatment of multiple conditions, including disseminated intravascular coagulation (DIC), acute respiratory distress syndrome (ARDS), and acute pancreatitis; Fedsyra, a pre-filled ephedrine syringe; and PFS-02, a pre-filled phenylephrine syringe.